Saturn V Capital Management LP 13F holdings, Q4 2025
Holdings as of December 31, 2025 · filings on SEC EDGAR · latest filing →
Saturn V Capital Management LP disclosed 20 US equity positions worth $544.9m in its Q4 2025 13F filing. The largest position was ABVX at 16.1% of the reported book, followed by AMLX and COGT. Against the Q3 2025 filing, it opened 8 new positions, added to 4 and reduced 8 among the top 20 holdings.
What did Saturn V Capital Management LP own in Q4 2025? Top 20 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2025 |
|---|---|---|---|---|---|---|---|
| 1 | ABVX ABIVAX SA | 16.1% | $87.5m | 649,179 | -19% | reduced | |
| 2 | AMLX AMYLYX PHARMACEUTICALS INC | Healthcare | 10.0% | $54.3m | 4,496,487 | -2% | reduced |
| 3 | COGT COGENT BIOSCIENCES INC | Healthcare | 7.9% | $43.2m | 1,217,064 | -40% | reduced |
| 4 | JAZZ JAZZ PHARMACEUTICALS PLC | Healthcare | 7.7% | $42.2m | 248,070 | -17% | reduced |
| 5 | PCVX VAXCYTE INC | Healthcare | 6.8% | $36.9m | 798,940 | 1% | added |
| 6 | DYN DYNE THERAPEUTICS INC | Healthcare | 6.4% | $35.0m | 1,788,616 | -33% | reduced |
| 7 | PHVS PHARVARIS N V | 5.8% | $31.6m | 1,140,033 | 29% | added | |
| 8 | CELC CELCUITY INC | Healthcare | 5.8% | $31.6m | 317,095 | -33% | reduced |
| 9 | ALMS ALUMIS INC | 5.6% | $30.6m | 3,135,953 | – | new | |
| 10 | IRON DISC MEDICINE INC | Healthcare | 4.3% | $23.7m | 298,429 | -12% | reduced |
| 11 | XFOR X4 PHARMACEUTICALS INC | 4.3% | $23.2m | 5,800,530 | – | new | |
| 12 | MNPR MONOPAR THERAPEUTICS INC | 3.9% | $21.3m | 325,701 | 110% | added | |
| 13 | IVVD INVIVYD INC | Healthcare | 3.5% | $19.1m | 7,735,386 | – | new |
| 14 | OCUL OCULAR THERAPEUTIX INC | Healthcare | 3.4% | $18.3m | 1,504,880 | 31% | added |
| 15 | IMMX IMMIX BIOPHARMA INC | 2.9% | $15.7m | 2,999,169 | – | new | |
| 16 | OCULIS HOLDING AG | 1.9% | $10.3m | 516,761 | – | new | |
| 17 | IKT INHIBIKASE THERAPEUTICS INC | 1.5% | $7.9m | 3,856,799 | – | new | |
| 18 | CNTA CENTESSA PHARMACEUTICALS PLC | 1.3% | $7.1m | 282,692 | -62% | reduced | |
| 19 | OVID OVID THERAPEUTICS INC | Healthcare | 0.7% | $4.1m | 2,500,000 | – | new |
| 20 | IVA INVENTIVA SA | 0.2% | $1.3m | 283,166 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.